Announcing the 2019 Pilot Project recipients

We are proud to support innovative, high-impact research into new ideas about the causes and treatment of dementias through our Pilot Project program. This program offers “kick-starter” research funding to junior investigators at the University of Michigan, Michigan State University, Wayne State University, and Veteran Affairs Ann Arbor Health System so that they can begin[…]

Rinne Lewy Body Dementia Team Attends International Conference in Las Vegas

Center staff, Stephen Campbell and Renee Gadwa, and Rinne LBD Initiative Support Group Facilitator, Mary Whitlock, traveled to Las Vegas last week for the International Lewy Body Dementia Conference. The conference, hosted by Cleveland Clinic and the Lewy Body Dementia Association at Caesar’s Palace, featured two tracks – a scientific track focused on what’s happening around[…]

Center Announces Openings in Junior Investigator Mentoring Program

The Michigan Alzheimer’s Disease Research Center (MADRC) is pleased to announce openings in its junior investigator mentoring program. This program has two aims. One, providing junior investigators entering the field of dementia research with a broad education about contemporary dementia research. Two, providing junior investigators with mentoring by experienced investigators in developing competitive grant applications. The[…]

Newly funded project supports research participant feedback

Dr. Annalise Rahman-Filipiak recently received funding from the National Institute of Health for her SHARED Project. The SHARED Project will support Dr. Rahman-Filipiak’s efforts to deliver personalized feedback protocols of Alzheimer’s disease risk disclosure information to diverse patients and their families. Earlier feedback about risk may allow for medical, legal, and social planning that could[…]

Recently published research regarding FTD and ALS made possible by Center Pilot Project funding

As part of our Center’s annual pilot project program, Dr. Sami Barmada and his team identified a potential therapeutic target for neurodegenerative conditions, including ALS and Frontotemporal dementia. ALS and Frontotemporal dementia (FTD) are similar in both pathology and genetics, and researchers have long known that most people with ALS and FTD accumulate deposits of[…]

Registration now open for 3rd Annual Beyond Amyloid Research Symposium

We are thrilled to announce the third annual professionals-focused Beyond Amyloid Research Symposium taking place on June 19 in Grand Rapids. The Symposium will be hosted by Michigan State University. We welcome keynote speakers Russell Swerdlow, MD, Director of the University of Kansas Alzheimer’s Disease Center and Linda Van Eldik, PhD, Director of the University[…]